INNOVATE (NYSE:VATE) Announces Earnings Results, Beats Estimates By $0.89 EPS

INNOVATE (NYSE:VATE) announced its earnings results on Thursday. The company reported ($1.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.18) by $0.89, Zacks reports. The firm had revenue of $364.80 million for the quarter, compared to the consensus estimate of $251.70 million.

Here are the key takeaways from INNOVATE’s conference call:

• Consolidated Q1 revenue rose 33% to $364.8 million, and adjusted EBITDA improved to $19.7 million from $7.2 million a year ago, helped by stronger infrastructure and life sciences performance.
• Infrastructure remained the growth engine, with DBM Global revenue up 35.1% to $357.9 million and adjusted EBITDA of $23 million, while adjusted backlog stayed at a robust $1.8 billion and management highlighted early progress on 2027 backlog.
• Life Sciences made regulatory and clinical progress, including CE mark approval for the TGFR Monitor and reusable sensor, successful audit completion, and multiple IDE approvals that should support upcoming clinical enrollment.
• R2 saw solid demand momentum with $1.6 million in Q1 revenue, $2.2 million in total demand, and a backlog of about 160 systems globally, though management said the business is looking to raise external capital to continue its progress.
• Spectrum continued to face pressure from softer advertising demand and network cancellations, as revenue fell to $5.3 million and adjusted EBITDA slipped to $0.7 million, even as the company pointed to regulatory and strategic opportunities ahead.

INNOVATE Price Performance

Shares of NYSE VATE opened at $11.90 on Friday. The stock has a market capitalization of $162.27 million, a P/E ratio of -2.45 and a beta of 2.27. The company has a 50-day moving average price of $8.17 and a 200-day moving average price of $6.24. INNOVATE has a 1 year low of $3.75 and a 1 year high of $13.46.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of INNOVATE in a research note on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat, INNOVATE currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in VATE. Squarepoint Ops LLC purchased a new position in INNOVATE during the third quarter worth about $58,000. Bank of America Corp DE boosted its holdings in INNOVATE by 13.4% during the third quarter. Bank of America Corp DE now owns 18,962 shares of the company’s stock worth $93,000 after purchasing an additional 2,236 shares during the last quarter. Citadel Advisors LLC boosted its holdings in INNOVATE by 60.2% during the third quarter. Citadel Advisors LLC now owns 37,694 shares of the company’s stock worth $184,000 after purchasing an additional 14,163 shares during the last quarter. Finally, Jane Street Group LLC purchased a new position in INNOVATE during the fourth quarter worth about $51,000. 34.28% of the stock is currently owned by hedge funds and other institutional investors.

INNOVATE Company Profile

INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.